AE Wealth Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.18M Buy
91,755
+1,253
+1% +$98K 0.05% 301
2025
Q1
$6.56M Buy
90,502
+14,334
+19% +$1.04M 0.06% 296
2024
Q4
$5.64M Buy
76,168
+72,148
+1,795% +$5.34M 0.05% 323
2024
Q3
$265K Sell
4,020
-598
-13% -$39.5K ﹤0.01% 1072
2024
Q2
$427K Buy
4,618
+594
+15% +$54.9K ﹤0.01% 926
2024
Q1
$385K Sell
4,024
-19,205
-83% -$1.84M ﹤0.01% 891
2023
Q4
$1.7M Sell
23,229
-5,142
-18% -$377K 0.01% 960
2023
Q3
$1.97M Sell
28,371
-52,036
-65% -$3.61M 0.01% 855
2023
Q2
$7.58M Buy
80,407
+14,543
+22% +$1.37M 0.05% 433
2023
Q1
$5.45M Buy
65,864
+41,469
+170% +$3.43M 0.04% 486
2022
Q4
$1.82M Buy
24,395
+1,972
+9% +$147K 0.01% 784
2022
Q3
$1.85M Sell
22,423
-2,373
-10% -$196K 0.01% 724
2022
Q2
$2.36M Buy
24,796
+1,361
+6% +$129K 0.02% 613
2022
Q1
$2.76M Sell
23,435
-1,732
-7% -$204K 0.02% 616
2021
Q4
$3.26M Sell
25,167
-5,290
-17% -$685K 0.02% 542
2021
Q3
$3.45M Buy
30,457
+7,513
+33% +$851K 0.03% 471
2021
Q2
$2.38M Sell
22,944
-6,718
-23% -$696K 0.02% 580
2021
Q1
$2.48M Buy
29,662
+1,614
+6% +$135K 0.03% 514
2020
Q4
$2.56M Sell
28,048
-2,291
-8% -$209K 0.03% 430
2020
Q3
$2.42M Buy
30,339
+9,883
+48% +$789K 0.03% 384
2020
Q2
$1.41M Buy
20,456
+668
+3% +$46.2K 0.02% 509
2020
Q1
$1.24M Buy
19,788
+9,792
+98% +$616K 0.03% 424
2019
Q4
$777K Buy
9,996
+3,603
+56% +$280K 0.02% 587
2019
Q3
$469K Sell
6,393
-48
-0.7% -$3.52K 0.01% 633
2019
Q2
$397K Sell
6,441
-1,992
-24% -$123K 0.01% 652
2019
Q1
$538K Buy
+8,433
New +$538K 0.04% 327
2018
Q4
Sell
-4,344
Closed -$252K 513
2018
Q3
$252K Sell
4,344
-201
-4% -$11.7K 0.01% 495
2018
Q2
$221K Buy
+4,545
New +$221K 0.02% 399